Sartorius Unveils New 52W High

Keineui · 2026-09-24T14:21:05.264884Z

$$SRT has recovered significantly and reached a new 52-week high today. Analysts’ median price target is €243 https://de.tradingview.com/symbols/XETR-SRT/forecast-price-target/ I took advantage of the rally and set a trailing stop-loss just below the high. I’d rather get out with a 35% loss than waste any more time with them for much longer and at a much lower price. What do you think $SRT ? Do you have high hopes for the company, and do you still see potential in bioprocessing?

$SRT (-2,99%) It's been sitting like a dead weight in my portfolio since February 2025. A friend recommended it to me back then, and I jumped in without doing much research of my own. Right now, I’m down about 45%.

Now I’ve read up a bit on the company and looked at the current and projected figures, and the projections in particular look good:

https://de.marketscreener.com/kurs/aktie/SARTORIUS-AG-436557/finanzen/

2025 marked the turnaround, and things are expected to pick up starting in 2026:

2025 2026 2027

Revenue 4.6% 6% 9.45%

EBITDA 11.28% 6.8% 12.69%

FCF -31% 13.4% 31.9%

To me, this looks like a good turnaround case, so I’m considering holding onto my position for now and waiting it out—or possibly buying more if necessary.

Of 20 analysts, 14 see a buy signal with an average price target of €266. That would be a nice boost.

What does the community think $SRT (-2,99%) ? Should we steer clear of biopharma in Germany, or do you see a case here as well? Is it better to take the loss? Should we wait for the trend to turn or even add to our position?

As of July 1, 2026, 4:30 p.m.

Price: €188.90

Sartorius Unveils New 52W High-

Sartorius—sell or hold?